Davidson Kempner Capital Management’s Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock ARCK Stock Holding History

Davidson Kempner Capital Management’s Portfolio ARCK Stock Details ARCK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-350,000	Closed	-$3.54M	–	493
2022 Q3	$3.54M	Hold	350,000	–	–	0.06%	254
2022 Q2	$3.51M	Hold	350,000	–	–	0.06%	262
2022 Q1	$3.5M	Buy	+350,000	New	+$3.5M	0.05%	292

Other funds holding ARCK

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Davidson Kempner Capital Management's ARCK Position: Q4 2022 in Review

Davidson Kempner Capital Management sold out of Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) in Q4 2022, closing a stake of 350,000 shares — an estimated $3.54M sold.

Davidson Kempner Capital Management first reported a position in ARCK in Q1 2022 and held it in 3 quarters. The position peaked at $3.54M in Q3 2022. 2 funds tracked by Wall St. Rank hold ARCK as of Q4 2022.

Davidson Kempner Capital Management reported no remaining Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Davidson Kempner Capital Management sold 350,000 Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock shares in Q4 2022, an estimated $3.54M.
Davidson Kempner Capital Management first reported a position in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock in Q1 2022 and held it in 3 quarters.
Davidson Kempner Capital Management's Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position peaked at $3.54M in Q3 2022.
2 funds tracked by Wall St. Rank held Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock as of Q4 2022.

Based on Davidson Kempner Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.